[Disorders of carbohydrate metabolism following diuretically effective agents].
D001161:Arteriosclerosis / Q000150:complications; D050260:Carbohydrate Metabolism; D002740:Chlorothiazide / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000209:etiology; D003981:Diazoxide / Q000494:pharmacology*; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007328:Insulin / Q000097:blood; D010182:Pancreatic Diseases / Q000209:etiology; D011188:Potassium / Q000378:metabolism
D007328:Insulin; D006852:Hydrochlorothiazide; D002740:Chlorothiazide; D005665:Furosemide; D003981:Diazoxide; D011188:Potassium
Störungen im Kohlenhydratstoffwechsel nach Gabe diuretisch wirksamer Substanzen.